Summary

  • The US Department of Health and Human Services (HHS) has cancelled 22 contracts and investments worth almost $500m as it winds down funding for mRNA vaccine research.
  • The move is part of a wider strategy to scale down research into RNA-related infectious diseases, which has been promoted by HHS secretary Robert F Kennedy Jr, who cancelled a $590m contract with Moderna for a bird flu vaccine in May.
  • However, the Biden administration has said it remains open to research into mRNA treatments for cancer and other genetic disorders.
  • mRNA vaccines were developed and authorised during the Trump administration as part of Operation Warp Speed, and offered a faster route to vaccination than traditional methods.
  • The technology’s success in fighting COVID-19 sparked interest in using it against other diseases, but it has also faced scrutiny in the wake of rare cases of heart inflammation in young people who received the shots.
  • Despite the scaling down of research into RNA-related infectious diseases, HHS continues to invest in ongoing research on applications for oncology and other complex diseases.

By Emily Mullin

Original Article